Company Overview
| Stock Name | 金嗓子控股集團有限公司 |
|---|---|
| Stock Code | 06896 |
| Company Full Name | 金嗓子控股集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國從事制造及銷售藥品、保健食品及其他產品。 |
| Listing Date | 2015-07-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣西壯族自治區柳州市躍進路28號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.goldenthroat.com |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 4.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 9.3% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 83,531,400 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 4.87 |
|---|---|
| First Day Open | HK$ 4.71 |
| First Day Change | 5.87% |
| First Day Volume | 22025000.0 |
| First Day Turnover | 107332000.0 |
Use of Proceeds
| Use of Proceeds | 1、約23%（或175.9百萬港元）將用于興建位于廣西壯族自治區柳州市洛維工業集中區或替代土地的新藥品生產及研發基地； 2、約21%（或160.6百萬港元）將用于將我們現時位于廣西壯族自治區柳州市躍進路28號的總部改造成食品生產廠房及食品研發中心； 3、約32%（或244.7百萬港元）將用于2015年、2016年及2017年的市場擴展； 4、約9%（或68.8百萬港元）將用于產品開發； 5、約4%（或30.6百萬港元）將用于在我們現時位于廣西壯族自治區來賓市的場地建立中草藥加工基地； 6、約1%（或7.6百萬港元）將用于改進及升級我們的電子追蹤碼系統以更好地監控我們藥品及食品的分銷； 7、余下約10%的款項（或76.5百萬港元）將用作我們的營運資金及其他一般公司用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Overall Coordinators (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Bookrunners (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Joint Lead Managers (1)
Credit Suisse (Hong Kong) Limited CE AAO017
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Super Silverwood Limited | 155,999,800 HKD | — | 4.70% | — | 6 months | 2016-01-15 |
| 2 | 广州润钿营销策划有限公司 | 77,999,900 HKD | — | 2.30% | — | 6 months | 2016-01-15 |
| 3 | 康健企业咨询及投资有限公司 | 46,798,100 HKD | — | 1.40% | — | 6 months | 2016-01-15 |
| 4 | 中国新锐医药控股有限公司 | 31,199,500 HKD | — | 0.90% | — | 6 months | 2016-01-15 |
Directors & Management
| Chairman | 江佩珍 |
|---|---|
| Company Secretary | 區泳嫻 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 曾勇及家族成員(69.79%);Jin Chen Employee Holdings Limited(7.97%) |
|---|
